Stay updated on Ribociclib and Trametinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.

Latest updates to the Ribociclib and Trametinib in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of the Phase Ib and Phase II studies for pancreatic and colorectal cancers, as well as the decision not to proceed with the Phase II part of the study. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference27%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Ribociclib and Trametinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ribociclib and Trametinib in Solid Tumors Clinical Trial page.